Dallas/Fort Worth Research Site Investigating Medical Device Proven to Restore Vision and Improve Quality of Life in Seniors
Cornea Consultants of Texas is participating in a nationwide clinical trial of the Implantable Miniature Telescope (by Dr. Isaac Lipshitz), a medical device already FDA approved for patients with the most advanced form of macular degeneration (AMD) who have not yet had surgery to remove a cataract.
The clinical trial will evaluate the safety and effectiveness of the device in patients with End-Stage AMD who already had their cataract removed from the eye chosen to be implanted.
“Cornea Consultants of Texas has been offering the telescope implant to patients who haven’t had their cataract removed in the Dallas/Ft. Worth area since 2013,” said Dr. Aaleya Koreishi, M.D. “We’ve been impressed with patients’ progress and improved quality of life following the out-patient procedure as they become proficient in using this remarkable, implanted device. “
The telescope implant is not a cure for End-Stage AMD. As with any medical intervention, potential risks and complications exist with the telescope implant. Possible side effects include decreased vision or vision-impairing corneal swelling. The risks and benefits associated with the telescope implant are discussed in the Patient Information Booklet available at www.CentraSight.com and will be evaluated with each patient who might be a candidate for this study
Cornea Consultants of Texas is actively seeking patients to participate in the telescope implant treatment program. For more information, please call Jessica Yarborough, Cornea Consultants of Texas, at 817-529-3100 or visit www.CentraSight.com or call 1-855-550-1041.